Haleon plc

NYSE:HLN USA Drug Manufacturers - Specialty & Generic
Market Cap
$47.20 Billion
Market Cap Rank
#434 Global
#343 in USA
Share Price
$10.60
Change (1 day)
+1.34%
52-Week Range
$8.72 - $11.41
All Time High
$11.41
About

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene… Read more

Haleon plc (HLN) - Total Assets

Latest total assets as of June 2025: $31.83 Billion USD

Based on the latest financial reports, Haleon plc (HLN) holds total assets worth $31.83 Billion USD as of June 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Haleon plc - Total Assets Trend (2019–2024)

This chart illustrates how Haleon plc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Haleon plc - Asset Composition Analysis

Current Asset Composition (December 2024)

Haleon plc's total assets of $31.83 Billion consist of 16.7% current assets and 83.3% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 6.4%
Accounts Receivable $1.90 Billion 5.6%
Inventory $1.19 Billion 3.5%
Property, Plant & Equipment $1.92 Billion 5.6%
Intangible Assets $18.01 Billion 52.5%
Goodwill $8.20 Billion 23.9%

Asset Composition Trend (2019–2024)

This chart illustrates how Haleon plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Haleon plc's current assets represent 16.7% of total assets in 2024, an increase from 16.3% in 2019.
  • Cash Position: Cash and equivalents constituted 6.4% of total assets in 2024, up from 1.0% in 2019.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 75.0% of total assets, a decrease from 77.0% in 2019.
  • Asset Diversification: The largest asset category is intangible assets at 52.5% of total assets.

Haleon plc Competitors by Total Assets

Key competitors of Haleon plc based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
USA $67.26 Billion
Kamada
NASDAQ:KMDA
USA $378.79 Million
One World Pharma Inc
OTCQB:OWPC
USA $6.62 Million
Dongwha Pharm.Co.Ltd
KO:000020
Korea ₩654.63 Billion
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
China CN¥27.28 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
China CN¥4.97 Billion
Kotra Industries Bhd
KLSE:0002
Malaysia RM363.90 Million

Haleon plc - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.24 - 0.33

Lower asset utilization - Haleon plc generates 0.33x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: 1.83% - 4.20%

Moderate ROA - For every $100 in assets, Haleon plc generates $ 4.20 in net profit.

Haleon plc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.87 0.84 1.24
Quick Ratio 0.63 0.58 1.01
Cash Ratio 0.14 0.09 0.00
Working Capital $-620.00 Million $ -914.00 Million $ 1.01 Billion

Haleon plc - Advanced Valuation Insights

This section examines the relationship between Haleon plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.30
Latest Market Cap to Assets Ratio 1.45
Asset Growth Rate (YoY) 0.8%
Total Assets $34.31 Billion
Market Capitalization $49.87 Billion USD

Valuation Analysis

Above Book Valuation: The market values Haleon plc's assets above their book value (1.45 x), reflecting positive investor sentiment about the company's future prospects.

Positive Asset Growth: Haleon plc's assets grew by 0.8% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Haleon plc (2019–2024)

The table below shows the annual total assets of Haleon plc from 2019 to 2024.

Year Total Assets Change
2024-12-31 $34.31 Billion +0.76%
2023-12-31 $34.05 Billion -2.18%
2022-12-31 $34.81 Billion +1.06%
2021-12-31 $34.45 Billion +0.94%
2020-12-31 $34.13 Billion -4.43%
2019-12-31 $35.71 Billion --